Federal Register / Vol. 72, No. 117 / Tuesday, June 19, 2007 / Notices 33763 

self-sufficiency services for parents, 

parent skills training, and high-quality 

child care for children in low-income 

families in Kansas and Missouri. 

The purpose of the current document 

is to request public comment on the 36- 

month participant survey in 

Philadelphia. The research team plans 

to collect participant-reported surveys 

assessing participants’ employment, 

education and economic outcomes, 

participation in employment and 

training services, receipt of benefits and 

services such as food stamps and mental 

health services, housing and household 

information, health and health care 

coverage, child care, and child 

outcomes. 

The follow-up survey at the 36-month 

follow-up in Philadelphia will be used 

for the following purposes: To study the 

extent to which pre-employment 

services and transitional employment 

affect employment, earnings, income, 

and welfare dependence of low-income 

TANF recipients; to examine the 

impacts of these services on 

participants’ health, receipt of benefits 

such as food stamps, Medicaid, and 

child-care subsidies, and participation 

in services such as substance abuse 

treatment and mental health services; 

and to collect data on a wider range of 

outcomes measures than is available 

through welfare, Medicaid, Food 

Stamps, Social Security, and 

Unemployment Insurance records. 

The 36-month data collection effort 

draws heavily from the 15-month survey 

conducted in this site. Materials for the 

15-month data collection effort were 

previously submitted to OMB and were 

approved (OMB Control No. 0970–

0276). 

Respondents: TANF recipients 

without a high school diploma and/or 

recipients who have received TANF for 

at least 12 months. 

The fielded sample of the 36-month 

data collection effort will be all 1,944 

participants in the two program groups 

and the control group of the HtE project 

in Philadelphia. The burden estimates 

below assume an 80 percent response 

rate of the fielded sample. 

The annual burden estimates are 

detailed below, and the substantive 

content of each component will be 

detailed in the supporting statement 

attached to the forthcoming 30-day 

notice. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Philadelphia 36-month participant survey ........................................................ 1,555 1 0.75 1,166 

Estimated Total Annual Burden 

Hours: 1,166. 

In compliance with the requirements 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Administration, 

Office of Information Services, 370 

L’Enfant Promenade, SW., Washington, 

DC 20447, Attn: ACF Reports Clearance 

Officer. E-mail address: 

infocollection@acf.hhs.gov. All requests 

should be identified by the title of the 

information collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Dated: June 13, 2007. 

Brendan Kelly, 

OPRE Reports Clearance Officer. 

[FR Doc. 07–2998 Filed 6–18–07; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Comment Request 

Title: Request for State Data Needed to 

Determine the Amount of a Tribal 

Family Assistance Grant. 

OMB No.: 0970–0173. 

Description: 42 U.S.C. 612 (Section 

412 of the Social Security Act) gives 

federally recognized Indian Tribes the 

opportunity to apply to operate a Tribal 

Temporary Assistance for Needy 

Families (TANF) program. The Act 

specifies that the Secretary shall use 

State-submitted data to determine the 

amount of the grant to the Tribe. This 

form (letter) is used to request those 

data from the States. ACF is proposing 

to extend this information collection 

without change. 

Respondents: States that have Indian 

Tribes applying to operate a TANIF 

program. 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Request for State Data Needed to Determine the Amount of a Tribal Family 

Assistance Grant .......................................................................................... 15 1 42 630 


rwilkins on PROD1PC63 with NOTICES
33764 Federal Register / Vol. 72, No. 117 / Tuesday, June 19, 2007 / Notices 

Estimated Total Annual Burden 

Hours: 630. 

Additional Information: Copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families, Office of 

Administration, Office of Information 

Services, 370 L’Enfant Promenade, SW., 

Washington, DC 20447, Attn: ACF 

Reports Clearance Officer. All requests 

should be identified by the title of the 

information collection. E-mail address: 

infocollection@acf.hhs.gov. 

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, FAX: 202–395–6974, 

Attn: Desk Officer for the 

Administration for Children and 

Families. 

Dated: June 14, 2007. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 07–3004 Filed 6–18–07; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Cellular, Tissue, and Gene Therapies 

Advisory Committee; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). At least one portion of the 

meeting will be closed to the public. 

Name of Committee: Cellular, Tissue, 

and Gene Therapies Advisory 

Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held by teleconference on July 26, 2007 

from 11 a.m. to approximately 3:15 p.m. 

Location: National Institutes of 

Health, Bldg. 29B, Conference rms. A/B, 

9000 Rockville Pike, Bethesda, MD. This 

meeting will be held by teleconference. 

The public is welcome to attend the 

meeting at the specified location. A 

speakerphone will be provided at the 

specified location for public 

participation in the meeting. Important 

information about transportation and 

directions to the NIH campus, parking, 

and security procedures is available on 

the Internet at http://www.nih.gov/ 

about/visitor/index.htm. Visitors must 

show two forms of identification, one of 

which must be a government-issued 

photo identification such as a Federal 

employee badge, driver’s license, 

passport, green card, etc. If you are 

planning to drive to and park on the 

NIH campus, you must enter at the 

South Dr. entrance of the campus which 

is located on Wisconsin Ave. (the 

Medical Center Metro entrance), and 

allow extra time for vehicle inspection. 

Detailed information about security 

procedures is located at http:// 

www.nih.gov/about/visitorsecurity.htm. 

Due to the limited available parking, 

visitors are encouraged to use public 

transportation. 

Contact Person: Gail Dapolito or 

Danielle Cubbage, Center for Biologics 

Evaluation and Research, Food and 

Drug Administration, 1401 Rockville 

Pike, Rockville, MD, 20852, 301–827–

0314, or FDA Advisory Committee 

Information Line, 1–800–741–8138 

(301–443–0572 in the Washington, DC 

area), code 3014512389. Please call the 

Information Line for up-to-date 

information on this meeting. A notice in 

the Federal Register about last minute 

modifications that impact a previously 

announced advisory committee meeting 

cannot always be published quickly 

enough to provide timely notice. 

Therefore, you should always check the 

agency’s Web site and call the 

appropriate advisory committee hot 

line/phone line to learn about possible 

modifications before coming to the 

meeting. 

Agenda: On July 26, 2007, the 

committee will meet in open session to 

hear updates of research programs in: 

(1) The Division of Therapeutic Proteins 

and the Division of Monoclonal 

Antibodies, Office of Biotechnology 

Products, Center for Drug Evaluation 

and Research, FDA and (2) the Division 

of Cellular and Gene Therapies, Office 

of Cellular, Tissue, and Gene Therapies, 

Center for Biologics Evaluation and 

Research, FDA. 

FDA intends to make background 

material available to the public no later 

than 2 business days before the meeting. 

If FDA is unable to post the background 

material on its Web site prior to the 

meeting, the background material will 

be made publicly available at the 

location of the advisory committee 

meeting, and the background material 

will be posted on FDA’s Web site after 

the meeting. Background material is 

available at http://www.fda.gov/ohrms/ 

dockets/ac/acmenu.htm, click on the 

year 2007 and scroll down to the 

appropriate advisory committee link. 

Procedure: On July 26, 2007, from 11 

a.m. to approximately 2 p.m., the 

meeting is open to the public. Interested 

persons may present data, information, 

or views, orally or in writing, on issues 

pending before the committee. Written 

submissions may be made to the contact 

person on or before July 12, 2007. Oral 

presentations from the public will be 

scheduled between approximately 1 

p.m. and 2 p.m. Those desiring to make 

formal oral presentations should notify 

the contact person and submit a brief 

statement of the general nature of the 

evidence or arguments they wish to 

present, the names and addresses of 

proposed participants, and an 

indication of the approximate time 

requested to make their presentation on 

or before July 18, 2007. Time allotted for 

each presentation may be limited. If the 

number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, FDA may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by July 19, 2007. 

Closed Committee Deliberations: On 

July 26, 2007, from approximately 2:15 

p.m. to 3:30 p.m., the meeting will be 

closed to permit discussion where 

disclosure would constitute a clearly 

unwarranted invasion of personal 

privacy (5 U.S.C. 552b(c)(6)). The 

committee will discuss reports of 

intramural research programs and make 

recommendations regarding personnel 

staffing decisions. 

Persons attending FDA’s advisory 

committee meetings are advised that the 

agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Gail Dapolito 

at least 7 days in advance of the 

meeting. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: June 11, 2007. 

Randall W. Lutter, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E7–11728 Filed 6–18–07; 8:45 am] 

BILLING CODE 4160–01–S 


rwilkins on PROD1PC63 with NOTICES